Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis

この研究はインパクトが大きい可能性があると判断されました。 OEのAIによるハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文の影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することができ、読者は将来の診療を形成する可能性が最も高い論文に焦点を当てることができます。

研究概要

Fourteen healthy participants were included in this randomized, double-blind, cross-over study investigating the cerebral correlates of alertness in the human 5HT2A agonist and N-methyl-D-aspartic acid (NMDA) antagonist models of psychosis. Participants were administered both placebo and active drug [dimethyltryptamine (DMT) or S-ketamine] in two sessions with a 2-4 hour break between both conditions and a washout period of at least 14 days between sessions. Subjective drug effects were assessed using the Hallucinogenic Rating Scale (HRS) and the Abnormer psychischer Zustand (APZ) altered states of consciousness questionnaire. Schizophrenia-like symptoms were assessed using the the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS), the Scale for the Assessment of Negative Symptoms (SANS), and the Schizophrenia Proneness Instrument – Adult version (SPI-A). Visual and auditory alertness was also measured using a target-detection task with brain images being obtained through fMRI. Study results show that both drugs induced psychotic symptoms similar to those of schizophrenia. The intensity of hallucinogenic effect was similar for both drugs, with visual alterations being more pronounced after DMT. Overall, the administration of DMT led to decreased activation during both visual and auditory modalities, while S-ketamine increased activation during the auditory modality. An analysis of cue benefits revealed an attentional impairment particularly accompanied by DMT administration.